The Biomolecular Sciences Insitute (BSI) is a multidisciplianary institute devoted to advancing treatment for infectious diseases, cancer and neurological disorders. BSI is set up to promote and facilitate collaborative research in biomolecular science topics that represent areas of strength for FIU Faculty members.

The mission of this university-wide interdisciplinary academic center is to establish vibrant research and training programs under the general theme, "Molecular and Genomic Bases of Diseases and Therapeutics." Center research is focused in four areas: cancer, cardiovascular disease, infectious disease, and neurodegenerative disease.

For information regarding research on infectious diseases click here. 

Induced pathogenic inflammation is the hallmark of numerous human diseases, including the inflammatory bowel diseases, eosinophilic esophagitis, colon cancer, chronic infectious diseases, systemic pulmonary fibrosis, type 1 diabetes, wound healing, and the arthritides. The mission of the CIM is to elucidate the cellular and molecular basis of the inflammatory diseases in order to develop unique diagnostics and therapeutics for these disorders. We believe that targeted preventive or therapeutic strategies will become most effective when inflammatory cascades in host cells are understood in depth, and when the critical molecules involved in undesired induced inflammation are identified.

The mission of the FSU-COM Center for Medicine and Public Health is to promote collaboration, coordination, and integration of medicine and public health at all levels of practice (federal, state, and local), and across the entire continuum of prevention (primary, secondary, and tertiary). The center will promote more optimal and equitable health for individuals and communities through research, education, policy change, and innovation.

The Florida Atlantic University Center for Molecular Biology and Biotechnology was established to develop training programs in molecular biology and biotechnology, build strong research programs in functional genomics and related fields and serve as a magnet to attract biotechnology industry to this geographic area. The techniques used in molecular biology that have made possible the recent advances in genomics, are the basis of much of the pioneering work going on in virtually all fields of biology, and are fundamental to the entire biotechnology industry.

The Center is organized to facilitate both research and educational goals. To properly address USF's research and teaching mission, it is important to recognize the nature of the special blend and delicate balance between the two. The Center offers its members excellent opportunities to successfully combine the two elements. An interdisciplinary approach is essential when examining the molecular nature of human health issues. This approach facilitates the acquisition of new knowledge and allows development of therapeutic protocols. The Center has the capability of developing a therapeutic approach from a basic understanding of translational research and eventual testing in the clinic. The Center links faculty across USF with expertise on important aspects of this research issue and a keen interest, understanding and desire to accomplish USF's graduate education mission.

A center of excellence in molecular microbiology is needed to: function as an interdisciplinary and cohesive group of collaborating scientists who conduct research to discover the mechanisms of microbial pathogensis and invent, develop and apply novel technologies for the discovery of new antimicrobial targets, vaccines and diagnostics; serve as a group of faculty dedicated to the education and training of future scientists and clinicians who will be leaders in the field of cutting-edge technologies for the diagnosis, treatment and prevention of infectious diseases, and to promote the sharing of scientific information.

To improve patient outcomes by maximizing efficacy and minimizing toxicity of drug therapy through research, teaching, and service focused on genetically-guided drug therapy decision-making, drug discovery and drug development.

The mission of the University of Florida's Center for Pharmacometrics and Systems Pharmacology (CPSP) in the Department of Pharmaceutics of the College of Pharmacy is to foster the availability of safe, efficacious, and affordable drugs to patients by bridging the knowledge gap between drug discovery and the use of drugs in clinical practice. The CPSP provides the academic home to a multidisciplinary and integrative quantitative clinical pharmacology program in the discipline of drug development (DD), regulatory science (RS) and personalized (stratified) medicine with the objective of increasing success in the phase I to beginning of phase III clinical development space and enabling the advancement of individualization of therapy to improve the benefit/risk ratio of medicines.

The University of Florida has a rich environment of distinguished colleges, state-of-the-art research facilities and statewide health education and health delivery systems. These resources position UF at the forefront of institutions to train the next generation of clinical and translational investigators and to help overcome two major obstacles in our nation's clinical research enterprise: the translation of basic science discoveries to early investigations in humans and the translational of clinical research into better medical practice and healthcare delivery. UF has made considerable investments dedicated exclusively to accomplish these missions through the creation of a trans-institutional Clinical and Translational Science Institute (CTSI). The institute will provide the new intellectual home for clinical and translational research and training at UF, integrating and synergizing the scientific and educational activities of 16 colleges, two academic and clinical campuses, three regional healthcare systems and the 67 counties of the State of Florida.

This initiative focuses on relevant social, agricultural, scientific, clinical and educational issues related to diseases potentially devastating to the health of Floridians and the State economy, as well as the health and economy of rest of the country. This institute develops and delivers appropriate informatics, diagnostics, treatments and surveillance for the prediction, prevention, detection and management of microbial pathogen-associated diseases of humans, animals and plants.

Currently, the institute is a primary resource for all things related to COVID-19.

To develop, implement and evaluate evidence-based approaches to strengthen community capacity for sustained disease prevention and health promotion.

FREAC provides support to other university centers and departments as well as conducting its own research activities. Staff members, skilled in cartography, geographic information systems, multimedia programming, web design, and desktop publishing are utilized to complete projects dealing with resource management, environmental analysis, data analysis and formatting, and providing technical support to other university researchers. The Center maintains a large inventory of digital data that is available to government agencies and the private sector.

For more than 10 years, the GeoData Center has participated in collaborative interdisciplinary research for the UWF community and local, nonprofit, and private entities in Northwest FL. Our work crosses many disciplines: public health, economics, urban planning, conservation (land and animals), renewable energy, parks and recreation, and natural environments. We use our tools and technologies to help communities prepare for economic, social, and climate uncertainties.

The mission of the University of South Florida GHIDR Center is to bring together interdisciplinary research teams with expertise in diseases of global importance and transfer of technology with global and community partners to collaborate on developmental projects, train students and professionals and to strengthen and sustain healthy communities while improving quality of life. The USF GHIDR Center will be recognized for bringing together interdisciplinary translational research collaboration teams with expertise in diseases of importance.

The mission of the consortium is 

To be the catalytic platform to address the key challenges in global health affecting the large populations around the globe

To build a multidisciplinary internal, national and international collaborative partnerships to address urgent health crisis.

To promote education, interventions, innovations in health.

To improve the living conditions of communities through a sustainable and equitable balance between health and the environment.

The three pillars are:

• Antimicrobial resistance (AMR)
• Vector-borne Diseases
• Environmental Health
• Immunization 
• Heavy Metal Poisoning
• Diabetes

I-Health was created to advance health through pioneering research and practical applications. I-Health is redesigning the health care infrastructure to create novel intervention programs to provide patients and the community with health care for everyday needs as well as the most specialized services for complex diseases, illnesses, and injuries. I-Health also focuses on aging patient populations to provide unique care that is not available elsewhere in the region. In addition to developing clinical trials and conducting clinical and translational research, I-Health will teach and train generations of health care professionals to meet South Florida’s diverse needs.

The Institute for Therapeutic Innovation (ITI) has as a mission and focus of developing optimized chemotherapy for medically important Infectious Diseases. In contradistinction to other laboratories, ITI does not focus upon a specific pathogen, but we apply the same therapeutic principles to many different pathogens. Examples include nosocomial pathogens (Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella species, and MRSA), tuberculosis, Select Agents, Pandemic Influenza, HIV, Hepatitis C, and other bacterial and viral pathogens. We have developed unique and innovative model systems, including the hollow fiber infection model to probe for optimized drug regimens which kill pathogens and suppress resistance emergence. Distinctively, we apply cutting edge mathematical models to these data. This allows rapid identification of optimal regimens. This work is done to provide the best care for seriously infected patients.

The mission of the Institute of NeuroImmune Pharmacology is to develop and sustain a program of translational research and training in drug use/abuse and HIV. The Institute will be housed in the College of Medicine and will promote interdisciplinary translational research focusing on the interactions of the human immune system, substance use/abuse, and HIV infection and drug targeting.

The One Health Center of Excellence at the University of Florida focuses on understanding the interconnections between the health of humans, animals, plants, and the environment. The final objective of implementing the One Health vision is therefore the advancement of health as a system which has multiple stakeholders. The UF One Health Center invests in developing innovative interdisciplinary approaches on how to co-advance the health of humans, animals, plants and the environment by exploiting the big data environment.